| # | Title | Journal | Year | Citations |
|---|
| 1 | American Society of Hematology 2020 guidelines for treating newly diagnosed acute myeloid leukemia in older adults | Blood Advances | 2020 | 113 |
| 2 | Is the neutrophil-to-lymphocyte ratio prognostic of survival outcomes in gynecologic cancers? A systematic review and meta-analysis | Gynecologic Oncology | 2017 | 85 |
| 3 | Toward Biological Subtyping of Papillary Renal Cell Carcinoma With Clinical Implications Through Histologic, Immunohistochemical, and Molecular Analysis | American Journal of Surgical Pathology | 2017 | 75 |
| 4 | Is hormonal therapy effective in advanced endometrial cancer? A systematic review and meta-analysis | Gynecologic Oncology | 2017 | 71 |
| 5 | Lifestyle modifications for patients with breast cancer to improve prognosis and optimize overall health | Cmaj | 2017 | 67 |
| 6 | Endocrine therapy in endometrial cancer: An old dog with new tricks | Gynecologic Oncology | 2019 | 48 |
| 7 | Untapped “-omics”: the microbial metagenome, estrobolome, and their influence on the development of breast cancer and response to treatment | Breast Cancer Research and Treatment | 2020 | 33 |
| 8 | PANCREOX: A randomized phase 3 study of 5FU/LV with or without oxaliplatin for second-line advanced pancreatic cancer (APC) in patients (pts) who have received gemcitabine (GEM)-based chemotherapy (CT). | Journal of Clinical Oncology | 2014 | 32 |
| 9 | One-year efficacy and safety of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria naïve to complement inhibitor therapy: open-label extension of a randomized study | Therapeutic Advances in Hematology | 2020 | 24 |
| 10 | Toronto Workshop on Late Recurrence in Estrogen Receptor–Positive Breast Cancer: Part 1: Late Recurrence: Current Understanding, Clinical Considerations | JNCI Cancer Spectrum | 2019 | 15 |
| 11 | Province-Wide Analysis of Patient-Reported Outcomes for Stage IV Non-Small Cell Lung Cancer | Oncologist | 2021 | 13 |
| 12 | Chronobiological factors for compassion satisfaction and fatigue among ambulatory oncology caregivers | Chronobiology International | 2017 | 11 |
| 13 | Toronto Workshop on Late Recurrence in Estrogen Receptor-Positive Breast Cancer: Part 2: Approaches to Predict and Identify Late Recurrence, Research Directions | JNCI Cancer Spectrum | 2019 | 11 |
| 14 | Predictors of intensive care unit admission in patients with hematologic malignancy | Scientific Reports | 2020 | 11 |
| 15 | Prostate MRI versus PSA screening for prostate cancer detection (the MVP Study): a randomised clinical trial | BMJ Open | 2022 | 8 |
| 16 | Doctor, What Are My Options? a Prospective Cohort Study of an Individualized Care Plan for Patients with Gastrointestinal Cancer | Current Oncology | 2015 | 6 |
| 17 | Integrated Molecular Analysis of Papillary Renal Cell Carcinoma and Precursor Lesions Unfolds Evolutionary Process from Kidney Progenitor-Like Cells | American Journal of Pathology | 2019 | 6 |
| 18 | Management of anticoagulation in patients with metastatic castration–resistant prostate cancer receiving abiraterone + prednisone | Supportive Care in Cancer | 2019 | 5 |
| 19 | SARS-CoV-2 Testing for Asymptomatic Patients with Cancer Prior and during Treatment: A Single Centre Experience | Current Oncology | 2021 | 5 |
| 20 | Intraperitoneal chemotherapy: Hot, timely, and relevant? | Cancer | 2020 | 4 |
| 21 | RUNX1 mutations correlate with response to venetoclax combination therapies in relapsed/refractory acute myeloid leukemia | Leukemia Research | 2021 | 4 |
| 22 | Doctor, what are my options? A prospective cohort study of an individualized care plan for patients with gastrointestinal cancer. | Journal of Clinical Oncology | 2012 | 3 |
| 23 | Delivery of Virtual Care in Oncology: Province-Wide Interprofessional Consensus Statements Using a Modified Delphi Process | Current Oncology | 2021 | 3 |
| 24 | RE: Long-term Safety of Pregnancy Following Breast Cancer According to Estrogen Receptor Status | Journal of the National Cancer Institute | 2018 | 2 |
| 25 | The burden of red blood cell transfusions in patients with lower-risk myelodysplastic syndromes and ring sideroblasts: an analysis of the prospective MDS-CAN registry | Leukemia and Lymphoma | 2023 | 2 |
| 26 | Myelodysplastic syndrome | Cmaj | 2016 | 1 |
| 27 | Intensive versus less-intensive antileukemic therapy in older adults with acute myeloid leukemia: A systematic review | PLoS ONE | 2021 | 1 |
| 28 | First-Line Therapy, Autologous Stem-Cell Transplantation, and Post-Transplantation Maintenance in the Management of Newly Diagnosed Mantle Cell Lymphoma | Current Oncology | 2020 | 1 |
| 29 | Comparison of clinical outcomes between transplant and nontransplant therapies in myelofibrosis following failure of first‐line JAK‐inhibitor | American Journal of Hematology | 2023 | 1 |
| 30 | Editorial: Supportive and palliative care for older adults with cancer | Current Opinion in Supportive and Palliative Care | 2022 | 0 |
